Citeron-1

Citeron 1 is an ophthalmic solution containing 0.2% high molecular weight hyaluronic acid obtained by biotechnological synthesis. The presence of citicoline in Citeron 1 provides beneficial structural support in restoring the integrity of cell membranes damaged due to degenerative ocular pathologies (for example, glaucoma).

Ingredients: hyaluronic acid 0.2% w/v, citicoline monosodium salt 2% w/v, sodium phosphate monohydrate, sodium dihydrogen phosphate dodecahydrate, sodium chloride, benzalkonium chloride, water for injection.

• For irritation, burning and foreign body sensation caused by factors: wind, sun, dry air, salt water, smoke, bright light, air conditioning, heating, with prolonged use of gadgets;
• Using contact lenses;
• Glaucoma and optical glaucoma neuropathy;
• Diabetic retinopathy;
• Ischemic optic neuropathy;
• Macular degeneration;
• Degenerative diseases of the cornea;
• Changes in the fundus of the eye that are associated with hypertension: with angiopathy, angiosclerosis, retinopathy;
• Keratitis;
• Changes in the fundus of the eye associated with refractive errors: high myopia, high hyperopia;
• Amblyopia;
• Before and after keratorefractive surgeries: photorefractive keratotomy, LASIK, etc.

Directions for use: 1 drop 2-3 times a day as needed. The recommended course of treatment is 2 months three times a year, or for 4 months twice a year (depending on the stage of the disease).
Special instructions: Temporary blurred vision may occur after using the drug. It is recommended to wait a few seconds before starting any activity that requires clear vision.